Kyverna Therapeutics, Inc. - Common Stock (KYTX)

Kyverna Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for autoimmune diseases and related conditions

The company specializes in harnessing the power of engineered immune cells to create transformative treatment options. By utilizing advanced genetic engineering techniques, Kyverna aims to target and modify the immune system's response, thereby addressing the underlying causes of autoimmune disorders. Through its research and development initiatives, the company strives to deliver novel, effective solutions that improve patient outcomes and enhance quality of life for those affected by these challenging diseases.